Cipher Pharmaceuticals (TSX:CPH) EPS (Basic) : C$1.10 (TTM As of Dec. 2023)

View and export this data going back to 2004. Start your Free Trial

What is Cipher Pharmaceuticals EPS (Basic)?

Cipher Pharmaceuticals's basic earnings per share (Basic EPS) for the three months ended in Dec. 2023 was C$0.43. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Dec. 2023 was C$1.10.

Cipher Pharmaceuticals's EPS (Diluted) for the three months ended in Dec. 2023 was C$0.40. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was C$1.06.

Cipher Pharmaceuticals's EPS without NRI for the three months ended in Dec. 2023 was C$0.38. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Dec. 2023 was 1.03.

During the past 12 months, Cipher Pharmaceuticals's average EPS without NRIGrowth Rate was -25.10% per year. During the past 3 years, the average EPS without NRI Growth Rate was 41.20% per year. During the past 5 years, the average EPS without NRI Growth Rate was 59.60% per year. During the past 10 years, the average EPS without NRI Growth Rate was 6.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 13 years, Cipher Pharmaceuticals's highest 3-Year average EPS without NRI Growth Rate was 65.20% per year. The lowest was -47.00% per year. And the median was 18.60% per year.

Cipher Pharmaceuticals EPS (Basic) Historical Data

The historical data trend for Cipher Pharmaceuticals's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cipher Pharmaceuticals EPS (Basic) Chart

Cipher Pharmaceuticals Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

EPS (Basic)

Get a 7-Day Free Trial

0.16

0.22

0.37

1.43

1.10

Cipher Pharmaceuticals Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
EPS (Basic)	Get a 7-Day Free Trial															1.06	0.14	0.16	0.38	0.43

Cipher Pharmaceuticals EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Cipher Pharmaceuticals's Basic EPS for the fiscal year that ended in Dec. 2023 is calculated as

Basic EPS (A: Dec. 2023 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(27.346	-	0)	/	25.005
	=	1.09

Cipher Pharmaceuticals's Basic EPS for the quarter that ended in Dec. 2023 is calculated as

Basic EPS (Q: Dec. 2023 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(10.27	-	0)	/	24.256
	=	0.42

EPS (Basic) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was C$1.10

Cipher Pharmaceuticals (TSX:CPH) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Cipher Pharmaceuticals EPS (Basic) Related Terms

Thank you for viewing the detailed overview of Cipher Pharmaceuticals's EPS (Basic) provided by GuruFocus.com. Please click on the following links to see related term pages.

Cipher Pharmaceuticals (TSX:CPH) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Cipher Pharmaceuticals Inc (TSX:CPH) » Definitions » EPS (Basic)

Comparable Companies

Traded in Other Exchanges

CPHRF:USA PHE:Germany

Address

5750 Explorer Drive, Suite 404, Mississauga, ON, CAN, L4W 0A9

Website

https://www.cipherpharma.com

Cipher Pharmaceuticals Inc is a specialty pharmaceutical company. Its products include Dermatology Products, Hospital Acute Care Products, specialty medicines, and Out-Licensed Products among others. The company's geographical operational areas include Canada and the United States.

Cipher Pharmaceuticals (TSX:CPH) Headlines

No Headlines